Remedi Surges 23%; Bio Solution Climbs on China Expansion [K-bio pulse] 김진수 2026.08.19 오전 07:50 신테카바이오, AI 신약개발 플랫폼 특허 추가 취득 송영두 2025.01.22 오전 09:40 Syntekabio wins SI deal from HYBE’s Weverse unit 나은경 2025.12.17 오후 01:42 SyntekaBio Pushes AI Drug Discovery with 'DeepMatcher' 김새미 2025.09.26 오후 06:53 SyntekaBio, Panolos Sign MOU on Next-Gen Multispecific Antibodies 송영두 2025.12.05 오전 09:55 Syntekabio Rights Offering Aims at Stability, Growth Acceleration 송영두 2025.09.15 오후 08:59 Syntekabio, Teams Up with MSKCC for Next Cancer Drug 송영두 2025.10.16 오전 08:18 On Drug Momentum, ABPROBIO & Ildong Hit Limit Up; Syntekabio Jumps[K-Bio Pulse] 송영두 2025.11.06 오전 07:25 Peptron, Oncocross Hit Kosdaq Upper Limits as Obesity, AI Drug Themes Rally 임정요 2025.04.14 오전 07:35 Syntekabio Partners with U.S. Proteco on Universal COVID Drug 송영두 2025.04.22 오전 07:31 더 보기 로딩중..
Syntekabio
Syntekabio
![Remedi Surges 23%; Bio Solution Climbs on China Expansion [K-bio pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/08/PS26081900259b.jpg)
![On Drug Momentum, ABPROBIO & Ildong Hit Limit Up; Syntekabio Jumps[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/11/PS25110600233b.jpg)
